Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M167Revenue $M31.8Net Margin (%)77.0Z-Score
Enterprise Value $M286EPS $1.5Operating Margin %34.4F-Score5
P/E(ttm))7.0Cash Flow Per Share $0.4Pre-tax Margin (%)34.4Higher ROA y-yY
Price/Book0.910-y EBITDA Growth Rate %0Quick Ratio1.1Cash flow > EarningsN
Price/Sales5.35-y EBITDA Growth Rate %0Current Ratio1.1Lower Leverage y-yN
Price/Cash Flow18.1y-y EBITDA Growth Rate %350ROA % (ttm)2.7Higher Current Ratio y-yN
Dividend Yield %1.7Insider Buy (3m)0ROE % (ttm)13.3Less Shares Outstanding y-yY
Payout Ratio %8.0Shares Outstanding M17.2ROI % (ttm)4.7Gross Margin Increase y-yN

Gurus Latest Trades with FFNW

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
FFNWJohn Keeley 2009-09-30 Sold Out -0.09%$5.87 - $8.55
($7.45)
$ 10.237%Sold Out0
FFNWJohn Keeley 2008-09-30 Add0.03%$9.61 - $10.65
($10)
$ 10.22%Add 66.67%662,500
FFNWMichael Price 2008-09-30 Sold Out -0.31%$9.61 - $10.65
($10)
$ 10.22%Sold Out0
FFNWJohn Keeley 2008-06-30 Add0.04%$9.7 - $10.41
($10.1)
$ 10.21%Add 1123.08%397,500
FFNWJohn Keeley 2008-03-31 Add$8.94 - $9.92
($9.5)
$ 10.27%Add 62.5%32,500
FFNWMichael Price 2007-12-31 Buy 0.28%$9.97 - $11.65
($10.6)
$ 10.2-4%New holding, 145400 sh.145,400
FFNWJohn Keeley 2007-12-31 Buy $9.97 - $11.65
($10.6)
$ 10.2-4%New holding, 20000 sh.20,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

FFNW is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


FFNW: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Robinson Herman LSenior VP and CCO of the Bank 2013-10-30Sell12,786$10.81-7.31 view
KILEY JOSEPH W IIIPresident and CEO 2013-10-30Sell4,000$10.8-7.22 view
Karpiak VictorPresident & CEO of the Company 2013-08-19Sell25,000$10.39-3.56 view
Karpiak VictorPresident & CEO of the Company 2013-08-15Sell16,253$10.62-5.65 view
Karpiak VictorPresident & CEO of the Company 2013-08-13Sell21,401$10.65-5.92 view
Karpiak VictorPresident & CEO of the Company 2013-08-09Sell6,654$10.71-6.44 view
Karpiak VictorPresident & CEO of the Company 2013-08-07Sell13,505$10.71-6.44 view
Karpiak VictorPresident & CEO of the Company 2013-08-05Sell8,387$10.73-6.62 view
Karpiak VictorPresident & CEO of the Company 2013-08-01Sell15,600$10.77-6.96 view
Kohlwes Gary FDirector 2013-07-30Buy1,600$10.04-0.2 view

Press Releases about FFNW :

    Quarterly/Annual Reports about FFNW:

    News about FFNW:

    Articles On GuruFocus.com
    FIRST FINANCIAL NORTHWEST, INC. (FFNW) CEO Victor Karpiak buys 5,762 Shares Feb 24 2011 
    First Financial Northwest Corp (FFNW) – A “B-B-T-W-T-A-A-D-D” Special Situation Jun 29 2010 
    June 28, 2010 52-Week Low Wrap-Up: BP Plc, Carrols Restaurant, First Financial Northwest, Monsanto, Jun 28 2010 
    June 25, 2010 52-Week Low Wrap-Up: Blackrock, BP Plc, Community Bankers Trust, ENGlobal, First Finan Jun 25 2010 
    FIRST FINANCIAL NORTHWEST, INC. (FFNW) CEO Victor Karpiak buys 5,000 Shares May 10 2010 
    Guru Stocks at 52-Week Low: First Financial Northwest, Inc, Stericycle Inc, SAIC Inc, First BanCorp, Sep 27 2009 
    Guru Stocks at 52-Week Lows: Stericycle Inc, SAIC Inc, FIRST FINANCIAL NORTHWEST, INC, Orion Energy Sep 20 2009 
    Guru Stocks at 52-Week Low: Banco Ita Holding Financeira S.A, Open Solutions Inc, First Financial No Sep 13 2009 

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Hide